Pietrantonio F, Salvatore L, Esaki T, Modest DP, et al. Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer. J Clin Oncol 2025 Apr 11:JCO2402026. doi: 10.1200/JCO-24-02026.
PMID: 40215429